JBIO vs. ANGPY
JBIO (Jade Biosciences, Inc) and ANGPY (Anglo American Platinum ADR) are both stocks. JBIO operates in Biotechnology (Healthcare), while ANGPY operates in Other Precious Metals & Mining (Basic Materials). Over the past 5 years, JBIO returned 71.21%/yr vs -3.15%/yr for ANGPY. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
JBIO vs. ANGPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JBIO achieves a 28.00% return, which is significantly higher than ANGPY's -7.17% return.
JBIO
- 1D
- -1.25%
- 1M
- -8.18%
- 6M
- 26.52%
- YTD
- 28.00%
- 1Y
- 186.65%
- 3Y*
- 124.22%
- 5Y*
- 71.21%
- 10Y*
- —
- ALL TIME*
- 45.59%
ANGPY
- 1D
- 0.56%
- 1M
- 7.99%
- 6M
- -11.07%
- YTD
- -7.17%
- 1Y
- 74.62%
- 3Y*
- 23.34%
- 5Y*
- -3.15%
- 10Y*
- 13.93%
- ALL TIME*
- 18.76%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.91M | $1.80M | $2.02M | |
| $14.42M | $18.92M | $20.53M |
JBIO vs. ANGPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
JBIO Jade Biosciences, Inc | 28.00% | 5,473.10% | -88.29% | -22.76% | 148.52% | -57.89% |
ANGPY Anglo American Platinum ADR | -7.17% | 202.15% | -40.10% | -34.38% | -19.08% | 9.70% |
Correlation
The correlation between JBIO and ANGPY is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (3Y) Balances recent behavior with more history. | 0.13 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jun 30, 2021 | 0.13 |
Fundamentals
JBIO:
$644.36M
ANGPY:
$19.80B
JBIO:
-$2.65
ANGPY:
ZAR 23.28
JBIO:
3.85
ANGPY:
3.05
JBIO:
$0.00
ANGPY:
ZAR 250.65B
JBIO:
-$9.00K
ANGPY:
ZAR 64.89B
JBIO:
-$133.57M
ANGPY:
ZAR 70.42B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JBIO vs. ANGPY — Risk / Return Rank
JBIO
ANGPY
JBIO vs. ANGPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jade Biosciences, Inc (JBIO) and Anglo American Platinum ADR (ANGPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JBIO | ANGPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.21 | ||
| Sortino ratioReturn per unit of downside risk | +1.15 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.21 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 3.98 | 1.78 | +2.20 |
| Martin ratioReturn relative to average drawdown | 11.49 | 3.61 | +7.88 |
Loading charts...
Drawdowns
JBIO vs. ANGPY - Drawdown Comparison
The maximum JBIO drawdown since its inception was -95.41%, which is greater than ANGPY's maximum drawdown of -78.47%. Use the drawdown chart below to compare losses from any high point for JBIO and ANGPY.
Loading charts...
Drawdown Indicators
| JBIO | ANGPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.41% | -78.47% | -16.94% |
Max Drawdown (1Y)Largest decline over 1 year | -44.21% | -43.04% | -1.17% |
Max Drawdown (3Y)Largest decline over 3 years | -95.41% | -43.04% | -52.37% |
Max Drawdown (5Y)Largest decline over 5 years | -95.41% | -78.47% | -16.94% |
Max Drawdown (10Y)Largest decline over 10 years | — | -78.47% | — |
Current DrawdownCurrent decline from peak | -26.44% | -38.27% | +11.83% |
Average DrawdownAverage peak-to-trough decline | -44.62% | -35.26% | -9.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.27% | 21.18% | -5.91% |
Volatility
JBIO vs. ANGPY - Volatility Comparison
The current volatility for Jade Biosciences, Inc (JBIO) is 15.16%, while Anglo American Platinum ADR (ANGPY) has a volatility of 16.35%. This indicates that JBIO experiences smaller price fluctuations and is considered to be less risky than ANGPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JBIO | ANGPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.16% | 16.35% | -1.19% |
Volatility (6M)Calculated over the trailing 6-month period | 54.20% | 55.36% | -1.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.63% | 68.99% | +6.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 1,580.65% | 59.17% | +1,521.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 1,567.07% | 57.06% | +1,510.01% |
Dividends
JBIO vs. ANGPY - Dividend Comparison
JBIO has not paid dividends to shareholders, while ANGPY's dividend yield for the trailing twelve months is around 3.47%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
ANGPY Anglo American Platinum ADR | 3.47% | 3.87% | 3.40% | 4.85% | 15.62% | 10.20% | 2.91% | 0.99% | 1.11% |
JBIO Jade Biosciences, Inc | 0.00% | 15.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
JBIO vs. ANGPY - Financials Comparison
This section allows you to compare key financial metrics between Jade Biosciences, Inc and Anglo American Platinum ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
JBIO and ANGPY have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANGPY has higher volatility (16.35%) compared to JBIO (15.16%). In terms of maximum drawdown, JBIO dropped -95.41% vs ANGPY's -78.47%.
JBIO currently has the higher Sharpe Ratio (2.33 vs 1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JBIO and ANGPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer